Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Dysfunction in Spinal Muscular Atrophy
Eleonora Zilio, Valentina Piano, Brunhilde Wirth
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10878-10878
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Oxidative stress: Roles in skeletal muscle atrophy
Han Zhang, Guangdong Qi, Kexin Wang, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115664-115664
Closed Access | Times Cited: 98
Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
Abdullah Alhedaithy, Fouad Alghamdi, Momen Almomen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
Megi Meneri, Elena Abati, Delia Gagliardi, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1254-1254
Open Access | Times Cited: 17
Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape
Aleksei S. Ponomarev, Daria S. Chulpanova, Lina M. Yanygina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13743-13743
Open Access | Times Cited: 16
Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation
Tobias Graß, Zeynep Dokuzluoglu, Felix Buchner, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101659-101659
Open Access | Times Cited: 6
Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
Damien Meng-Kiat Leow, Yang Kai Ng, Loo Chien Wang, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 5
Pathophysiology and Management of Fatigue in Neuromuscular Diseases
Francesca Torri, Piervito Lopriore, Vincenzo Montano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5005-5005
Open Access | Times Cited: 11
AMPK is mitochondrial medicine for neuromuscular disorders
Andrew I. Mikhail, Sean Y. Ng, Stephanie R. Mattina, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 7, pp. 512-529
Open Access | Times Cited: 11
Critical Roles of Protein Arginine Methylation in the Central Nervous System
Ke-Wei Chang, Dan Gao, Jidong Yan, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 6060-6091
Closed Access | Times Cited: 10
Skeletal Muscle Mitochondrial and Autophagic Dysregulation Are Modifiable in Spinal Muscular Atrophy
Andrew I. Mikhail, Sean Y. Ng, Donald Xhuti, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy
Amber Hassan, Raffaella di Vito, Tommaso Nuzzo, et al.
Neurobiology of Disease (2025), pp. 106849-106849
Open Access
Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications
Andrej Belančić, Tamara Janković, Elvira Meni Maria Gkrinia, et al.
Neurology International (2025) Vol. 17, Iss. 3, pp. 41-41
Open Access
Network pharmacology approach to unravel the neuroprotective potential of natural products: a narrative review
Pankaj Kumar Singh, Maheshkumar R. Borkar, Gaurav Doshi
Molecular Diversity (2025)
Closed Access
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Newborn screening for spinal muscular atrophy - what have we learned?
Alzira Alves de Siqueira Carvalho, Cyril Tychon, Laurent Servais
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 11, pp. 1005-1012
Closed Access | Times Cited: 5
Long-Term SMN- and Ncald-ASO Combinatorial Therapy in SMA Mice and NCALD-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects
Anixa Muiños-Bühl, Roman Rombo, Karen Ling, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4198-4198
Open Access | Times Cited: 4
Altered Metabolism in Motor Neuron Diseases: Mechanism and Potential Therapeutic Target
Cassandra Barone, Xin Qi
Cells (2023) Vol. 12, Iss. 11, pp. 1536-1536
Open Access | Times Cited: 4
Mitochondrial dynamics and the significance of its disturbances in the development of childhood diseases. Part I. Physiological and neurological aspects
В. С. Сухоруков, Т. И. Баранич, А. В. Егорова, et al.
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) (2024) Vol. 69, Iss. 1, pp. 25-33
Open Access | Times Cited: 1
Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction
Francesca Torri, Michelangelo Mancuso, Gabriele Siciliano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7311-7311
Open Access | Times Cited: 1
Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
Ilaria Signoria, Maria M Zwartkruis, Lotte Geerlofs, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101379-101379
Open Access | Times Cited: 1
SMN Deficiency Induces an Early Non-Atrophic Myopathy with Alterations in the Contractile and Excitatory Coupling Machinery of Skeletal Myofibers in the SMN∆7 Mouse Model of Spinal Muscular Atrophy
Marı́a T. Berciano, Alaó Gatius, Alba Puente-Bedia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12415-12415
Open Access | Times Cited: 1
An isogenic human iPSC model unravels neurodevelopmental abnormalities in SMA
Tobias Graß, Ines Rosignol, J Thomas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)
Whitney Tang, Bo Gu, Samuel Montalvo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7582-7582
Open Access | Times Cited: 1
Physiological Features of the Neural Stem Cells Obtained from an Animal Model of Spinal Muscular Atrophy and Their Response to Antioxidant Curcumin
Raffaella Adami, Matteo Pezzotta, Francesca Cadile, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8364-8364
Open Access
SMN deficiency induces an early non-atrophic myopathy with alterations in the contractile and excitatory coupling machinery of skeletal myofibers in the SMNΔ7 mouse model of spinal muscular atrophy
Marı́a T. Berciano, Alaó Gatius, Alba Puente-Bedia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1 - Next Page

Scroll to top